论文信息 - OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation - 字舞流文

OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

G. Jerusalem | M. Krebs | L. Paz-Ares Rodríguez | H. Prenen | E. Massarelli | I. Walpole | A. Sacher | S. Mandlekar | M. D. de Miguel | K. Arbour | S. Bowyer | W. Miller | M. Patel | S. Han | M. Lin | M. Forster | T. Kim | J. Desai | N. Dharia | A. Falcón | P. Lorusso | M. Cheng | J. Schutzman | E. Garralda | E. Shacham‐Shmueli | J. Lee | S-W. Han | Y. Choi | S. Royer Joo | Z. Shi | E. Shacham-Shmueli | Y. Choi